Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2025-12-26 @ 1:29 PM
Study NCT ID:
NCT03548467
Status:
COMPLETED
Last Update Posted:
2023-04-21
First Post:
2018-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer
Sponsor:
Nykode Therapeutics ASA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-17
First Submit QC Date:
None
Study First Post Date:
2018-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-20
Last Update Post Date:
2023-04-21
Last Update Post Date Type:
ACTUAL